Photosensitizer-based small molecule theranostic agents for tumor-targeted monitoring and phototherapy

Bioorg Chem. 2023 Jul:136:106554. doi: 10.1016/j.bioorg.2023.106554. Epub 2023 Apr 19.

Abstract

Small molecule theranostic agents for tumor treatment exhibited triadic properties in tumor targeting, imaging, and therapy, which have attracted increasing attention as a potential complement for, or improved to, classical small molecule antitumor drugs. Photosensitizer have dual functions of imaging and phototherapy, and have been widely used in the construction of small molecule theranostic agents over the last decade. In this review, we summarized representative agents that have been studied in the field of small molecule theranostic agents based on photosensitizer in the last decade, and highlighted their characteristics and application in tumor-targeted monitoring and phototherapy. The challenges and future perspectives of photosensitizers in building small molecule theranostic agents for diagnosis and therapy of tumors were also discussed.

Keywords: Drug design; Photosensitizer; Phototherapy; Theranostic; Tumor-targeted imaging.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Cell Line, Tumor
  • Humans
  • Nanoparticles*
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / drug therapy
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Phototherapy
  • Precision Medicine

Substances

  • Photosensitizing Agents
  • Antineoplastic Agents